Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-28T03:26:05.599Z Has data issue: false hasContentIssue false
  • English
  • Français

The Role of CDC in the Development of AIDS Recommendations and Guidelines

Published online by Cambridge University Press:  28 April 2021

Verla S. Neslund ,
Gene W. Matthews  and
James W. Curran
Get access Rights & Permissions [Opens in a new window]

Extract

The role of the Centers for Disease Control (CDC) in the development of recommendations and guidelines on acquired immunodeficiency syndrome (AIDS) evolves from a tradition that originates in the earliest editions of the Morbidity and Mortality Weekly Report (MMWR). In 1961 responsibility for the Public Health Service's MMWR was transferred to CDC from the National Office of Vital Statistics. During the first decade that CDC published it, the MMWR continued the tradition of providing detailed statistics on reportable communicable diseases and unusual occurrences of disease or outbreaks of illness. Only rarely did editorial comments on the data appear. However, as early as 1962 the MMWR became the vehicle the Public Health Service used to publish the recommendations of the surgeon general's Oral Poliomyelitis Vaccine Advisory Committee, the predecessor of the current Immunization Practices Advisory Committee. This practice of publishing immunization and other public health recommendations in the MMWR has continued.

Type
Article
Information
Law, Medicine and Healthcare , Volume 15 , Issue 1-2 , Summer 1987 , pp. 73 - 79
Copyright
Copyright © American Society of Law, Medicine and Ethics 1987

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Centers for Disease Control (henceforth “CDC”), Special report: Reported paralytic poliomyelitis following oral vaccine, Morbidity and Mortality Weekly Report (henceforth “MMWR”), Sept. 28, 1962, 11: 198–99, 303-4.Google Scholar
CDC, Pneumocystis pneumonia—Los Angeles. MMWR, June 5, 1981, 30: 250–52.Google Scholar
CDC, Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men—New York City and California, MMWR, July 4, 1981, 30: 305–8.Google Scholar
CDC, Persistent, generalized lymphadenopathy among homosexual males, MMWR, May 21, 1982, 31: 249–52.Google Scholar
CDC, Pneumocystis carinii pneumonia among persons with hemophilia A, MMWR, July 16, 1982, 31: 365–67.Google Scholar
CDC, Acquired immune deficiency syndrome (AIDS): Precautions for clinical and laboratory staffs, MMWR, Nov. 5. 1982, 31: 577–80.Google Scholar
Id.: 577.Google Scholar
CDC, Possible transfusion-associated acquired immune deficiency syndrome (AIDS)—California, MMWR, Dec. 10, 1982, 31: 652–54.Google Scholar
CDC, Unexplained immunodeficiency and opportunistic infections in infants—New York, New Jersey, California, MMWR, Dec. 17, 1982, 31: 665–67.Google Scholar
CDC, Prevention of acquired immune deficiency syndrome (AIDS): Report of interagency recommendations, MMWR, March 4, 1983, 32: 101–4.Google Scholar
Id.: 101.Google Scholar
CDC, Acquired immunodeficiency syndrome (AIDS): Precautions for health-care workers and allied professionals, MMWR, Sept. 2, 1983, 32: 450–52.Google Scholar
CDC, Antibodies to a retrovirus etiologically associated with acquired immunodeficiency syndrome (AIDS) in populations with increased incidences of the syndrome, MMWR, July 13, 1984, 33: 377–79.Google Scholar
Subcommittee of International Committee for the Taxonomy of Viruses, Human immunodeficiency viruses (letter to the editor), Science, May 9, 1986, 232: 697.Google Scholar
CDC, Provisional Public Health Service interagency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome, MMWR, Jan. 11, 1985, 34: 1–5.Google Scholar
Id.: 3.Google Scholar
CDC, Update: Acquired immunodeficiency syndrome—United States, MMWR, May 10, 1985, 34: 245–48.Google Scholar
CDC, World Health Organization workshop: Conclusions and recommendations on acquired immunodeficiency syndrome, MMWR, May 17, 1985, 34: 275–76.Google Scholar
CDC, Testing donors of organs, tissues, and semen for antibody to human T-lymphotropic virus type III/lymphadenopathy-associated virus, MMWR, May 24, 1985, 34: 294.Google Scholar
Stewart, GJ, Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor, Lancet 1985, ii: 581–84.Google Scholar
Associated Press, Women tested for AIDS negative, Jan. 10, 1986 (press release available on NEXIS).Google Scholar
American Hospital Association, Management of HTLV-III/LAV infection in the hospital, rev. ed., 1986. See also Associated Press, Health organization recommends donated body parts be screened for AIDS, Dec. 10, 1985 (press release available on NEXIS).Google Scholar
Liver donor exposed to AIDS, New York Times, Jan. 9, 1986; Associated Press, Hospital officials say liver donor has AIDS antibodies, Jan. 8, 1986 (press release available on NEXIS); United Press International, Transplant organs contaminated with AIDS virus, August 29, 1986 (press release available on NEXIS).Google Scholar
CDC, Education and foster care of children infected with human T-lymphotropic virus type III/lymphadenopathyassociated virus, MMWR, Aug. 30, 1985, 34: 517–21.Google Scholar
See, Board of Education of City of Plainfield v. Cooperman, no. A-45/46 (Sup. Ct. of N.J., April 15, 1987); Application of Dist. 27 Community School v. Board of Education of City of New York, no. 14940/85 (Queens County Super. Ct., Feb. 11, 1986). See also Goldberg, , United Press International, AIDS outcry continues, Sept. 23, 1986 (press release available on NEXIS); Indiana teen with AIDS returns to school, American Medical News, April 25, 1986, at 10; United Press International, Appeals court hears AIDS case, Jan. 7, 1986 (press release available on NEXIS); Carroll, Associated Press, Federal judge declines to rule in AIDS schoolboy case, Aug. 16, 1985 (press release available on NEXIS); and Strauss, Associated Press, AIDS victim's suit seeks injunction against school, August 8, 1985 (press release available on NEXIS).Google Scholar
20 U.S.C.A. §§1401–54 (West 1978 and Supp. 1986).Google Scholar
29 U.S.C.A. §794 (West 1985 and Supp. 1985).Google Scholar
20 U.S.C.A. §1232g (West 1978 and Supp. 1986).Google Scholar
See, Board of Education of City of Plainfield and Application of Dist. 27 Community School Board, supra note 25.Google Scholar
CDC, Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace, MMWR, Nov. 15, 1986, 34: 681–86, 691-95.Google Scholar
Lewin, , Business and the law: AIDS and job discrimination, New York Times, April 15, 1986, at D2, col. 1.Google Scholar
Workplace recommendations, supra note 30, at 694.Google Scholar
CDC, Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures, MMWR, April 11, 1986, 35: 221–23.Google Scholar
Workplace guidelines, supra note 30, at 685–86.Google Scholar
CDC, Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome, MMWR, Dec. 6, 1985, 34: 721–26, 731-32.Google Scholar
CDC, Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associared virus, MMWR, March 14, 1986, 35: 152–55.Google Scholar
CDC, Immunization of children infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus, MMWR, Sept. 26, 1986, 34: 595–98, 603-6.Google Scholar
CDC, Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection, MMWR, April 11, 1986, 35: 231–33.Google Scholar
CDC, The safety of hepatitis B virus volume, MMWR, March 18, 1983, 32:134–36; CDC, Hepatitis B vaccine: Evidence confirming lack of AIDS transmission, MMWR, Dec. 14, 1984, 33: 685–87.Google Scholar
CDC, Diagnosis and management of mycobacterial infection and disease in persons with human T-lymphotropic virus type III/lymphadenopathy-associated virus, MMWR, July 18, 1986. 35: 448–52.Google Scholar
Recommended infection-control practices for dentistry, MMWR, April 18, 1986, 35: 237–42.Google Scholar
CDC, Recommendations for preventing possible transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus from tears, MMWR, Aug. 30, 1985, 34: 533–34.Google Scholar
CDC, Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus, MMWR, June 13, 1986, 35: 376–78.Google Scholar
42 U.S.C.A. §241(a)(1) (West 1982 and Supp. 1987).Google Scholar
Curran, W, Gostin, L, Clark, M, Acquired immunodeficiency syndrome: Legal and regulatory policy, report to U.S. Public Health Service pursuant to contract #282-86-0032, at pp. 379–81.Google Scholar